Moses Lake Pharmacy Recalls Alprostadil/Procaine Injectable Solution for Sterility Concerns
JD & SN Inc. is recalling 150 vials of Alprostadil/Procaine Injectable Solution due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of infection or serious injury.
Plain-English summary
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling 150 vials of Alprostadil/Procaine, Injectable Solution, 20 MCG/0.1%/ML, 10 mL vial. The recall was initiated because of a lack of assurance of sterility for all sterile human compounded drugs within their expiry dates.
The affected product is prescription-only and was distributed nationwide. The recall covers specific lots with expiration dates ranging from 2014 to 2015, including codes such as 01122015@4, 02022015@2, and t03062015@44.
Consumers and healthcare providers should stop using the recalled product and contact the pharmacy or their healthcare provider for further instructions.
The recalled product
- Product
- ALPROSTADIL/PROCAINE, Injectable Solution, 20 MCG/0.1%/ML, 10 mL vial, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Injectable Solution
- Affected units
- 150
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- 01122015@4
- 02022015@2
- 02102015@29
- 02202015@14
- 03302015@9
- 04132015@7
- 04222015@4
- 05062015@6
- 05132015@2
- 05272015@11
- 06032015@1
- 06102015@6
- 06222015@9
- 06232014@2
- 07082015@4
- 07112014@22
- 07292014@33
- 08182014@8
- 09022014@5
- 09092014@27
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereWells Pharmacy Recalls Alprostadil Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereMontana Compounding Pharmacy Recalls Alprostadil Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereRiverpoint Pharmacy Recalls Prostaglandin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-07-17
- SevereKey Pharmacy Recalls PGE1/Procaine Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- HighKey Pharmacy Recalls PGE1/Procaine Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SeverePharm D Solutions Recalls Bi-Mix Injection Due to Sterility Concerns
FDA (Drugs) · 2018-11-07